Hjem › Hjernetumorer › New York › New York City
Kliniske studier for Hjernetumorer i New York City, NY
25 studier for Hjernetumorer søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
RekruttererFase 2
- New York University Langone's Perlmutter Cancer Institute, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
- Columbia University Irving Medical Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruttererFase 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekruttererFase 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RekruttererFase 2
- Memorial Sloan-Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
RekruttererFase 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
RekruttererObservasjonsstudie
- Columbia University Irving Medical Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RekruttererFase 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
RekruttererFase 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Rekrutterer
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Rekrutterer
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
RekruttererFase 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
RekruttererFase 1
- Columbia University Irving Medical Center, New York
rTMS for Postoperative Brain Tumor Patients
Rekrutterer
- Columbia University Irving Medical Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
RekruttererFase 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
RekruttererFase 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
RekruttererFase 1
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
RekruttererFase 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Rekrutterer
- Memorial Sloan Kettering Cancer Center, New York
Hjernetumorer-studier i andre byer
- Houston, TX35 studier
- Boston, MA28 studier
- Washington, DC20 studier
- Los Angeles, CA16 studier
- Miami, FL15 studier
- Durham, NC14 studier
- St. Louis, MO12 studier
- Rochester, MN11 studier
- Chicago, IL11 studier
- Cleveland, OH11 studier
- Baltimore, MD11 studier
- Columbus, OH11 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.